← Leaderboards
Martha C Bohn
Children'S Memorial Hospital (Chicago)
$4,057,827
Attributed
$4,057,827
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $160.8K · FY2007–08$200K$150K$100K$50K$0
'07
'08
Funding mix
By agency
NIH$4,057,827 · 4
By mechanism
R01$3,572,629 · 2
R21$321,562 · 1
U54$163,636 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neurotrophic Factors”
- Keri Hammel · The Emmes Company, Llc$46,384,511
- Daniel M Corcos · Northwestern University$24,607,584
- Mark H Tuszynski · University Of California, San Diego$22,756,019
- John Morris · Washington University$20,760,190
- Michael E Greenberg · Dana-Farber Cancer Institute$20,203,606
- Baoji Xu · Georgetown University$17,872,599
Research focus
Neurotrophic FactorsTransfection /Expression VectorDisease /Disorder ModelParkinson'S DiseaseLaboratory RatGene TherapyGene ExpressionNeuronsNeurotoxinsTissue /Cell CultureExperimental Brain LesionCorpus StriatumTechnology /Technique DevelopmentDopamine Receptor6 HydroxydopamineDopamineSingle Cell AnalysisPolymerase Chain ReactionSubstantia NigraNeural DegenerationMicrodialysisNeurochemistryGliaAge Difference
Grant awards (14)
RNAi Gene Silencing of alpha-Synuclein for Parkinson's Disease$160,781
R21 · FY2008 · NS · contact PI
RNAi Gene Silencing of alpha-Synuclein for Parkinson's Disease$160,781
R21 · FY2007 · NS · contact PI
GENE THERAPHY FOR PARKINSON'S DISEASE$305,960
R01 · FY2004 · NS
IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA$504,176
R01 · FY2003 · NS
GENE THERAPHY FOR PARKINSON'S DISEASE$305,960
R01 · FY2003 · NS
IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA$492,618
R01 · FY2002 · NS
GENE THERAPHY FOR PARKINSON'S DISEASE$305,960
R01 · FY2002 · NS
TET regulated vectors for Parkinson's disease$163,636
U54 · FY2002 · NS
IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA$481,394
R01 · FY2001 · NS
GENE THERAPHY FOR PARKINSON'S DISEASE$305,960
R01 · FY2001 · NS
GENE THERAPHY FOR PARKINSON'S DISEASE$50,000
R01 · FY2001 · NS
IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA$453,641
R01 · FY2000 · NS
GENE THERAPHY FOR PARKINSON'S DISEASE$316,960
R01 · FY2000 · NS
IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA$50,000
R01 · FY2000 · NS